| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 159, Issue 8 3681-3691, Copyright © 1997 by American Association of Immunologists
ARTICLES |
AR Pettit, C Quinn, KP MacDonald, LL Cavanagh, G Thomas, W Townsend, M Handel and R Thomas
Centre for Immunology and Cancer Research, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia.
Dendritic cells (DC) are potent APCs that enter resting tissues as precursors and, after Ag exposure, differentiate and migrate to draining lymph nodes. The phenotype of RelB knockout mice implicates this member of the NF kappa B/Rel family in DC differentiation. To further elucidate the role of RelB in DC differentiation, mRNA, intracellular protein expression, and DNA binding activity of RelB were examined in immature and differentiated human DC, as well as other PB mononuclear cell populations. RelB protein and mRNA were detected constitutively in lymphocytes and in activated monocytes, differentiated DC, and monocyte-derived DC. Immunohistochemical staining demonstrated RelB within the differentiated lymph node interdigitating DC and follicular DC, but not undifferentiated DC in normal skin. Active nuclear RelB was detected by supershift assay only in differentiated DC derived from either PB precursors or monocytes and in activated B cells. These RelB+ APC were potent stimulators of the MLR. The data indicate that RelB expression is regulated both transcriptionally and post-translationally in myeloid cells. Within the nucleus, RelB may specifically transactivate genes that are critical for APC function.
This article has been cited by other articles:
|
|
 |
|
  C. Capini, M. Jaturanpinyo, H.-I Chang, S. Mutalik, A. McNally, S. Street, R. Steptoe, B. O'Sullivan, N. Davies, and R. Thomas Antigen-Specific Suppression of Inflammatory Arthritis Using Liposomes J. Immunol., March 15, 2009; 182(6): 3556 - 3565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Rowe, L. Lopes, N. Brown, S. Efklidou, T. Smallie, S. Karrar, P. M. Kaye, and M. K. Collins Expression of vFLIP in a Lentiviral Vaccine Vector Activates NF-{kappa}B, Matures Dendritic Cells, and Increases CD8+ T-Cell Responses J. Virol., February 15, 2009; 83(4): 1555 - 1562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wei, H. Wang, B. Lu, B. Li, S. Hou, W. Qian, K. Fan, J. Dai, J. Zhao, and Y. Guo Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells Cancer Res., May 15, 2008; 68(10): 3854 - 3862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. U. A. Mollah, S. Pai, C. Moore, B. J. O'Sullivan, M. J. Harrison, J. Peng, K. Phillips, J. B. Prins, J. Cardinal, and R. Thomas Abnormal NF-{kappa}B Function Characterizes Human Type 1 Diabetes Dendritic Cells and Monocytes J. Immunol., March 1, 2008; 180(5): 3166 - 3175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nencioni, J. Beck, D. Werth, F. Grunebach, F. Patrone, A. Ballestrero, and P. Brossart Histone Deacetylase Inhibitors Affect Dendritic Cell Differentiation and Immunogenicity Clin. Cancer Res., July 1, 2007; 13(13): 3933 - 3941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. P. A. MacDonald, R. D. Kuns, V. Rowe, E. S. Morris, T. Banovic, H. Bofinger, B. O'Sullivan, K. A. Markey, A. L. Don, R. Thomas, et al. Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during GVHD Blood, June 1, 2007; 109(11): 5049 - 5057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Andreakos, R. O. Williams, J. Wales, B. M. Foxwell, and M. Feldmann Activation of NF-{kappa}B by the intracellular expression of NF-{kappa}B-inducing kinase acts as a powerful vaccine adjuvant PNAS, September 26, 2006; 103(39): 14459 - 14464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Appel, V. Mirakaj, A. Bringmann, M. M. Weck, F. Grunebach, and P. Brossart PPAR-{gamma} agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-{kappa}B pathways Blood, December 1, 2005; 106(12): 3888 - 3894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Cejas, L. M. Carlson, J. Zhang, S. Padmanabhan, D. Kolonias, I. Lindner, S. Haley, L. H. Boise, and K. P. Lee Protein Kinase C {beta}II Plays an Essential Role in Dendritic Cell Differentiation and Autoregulates Its Own Expression J. Biol. Chem., August 5, 2005; 280(31): 28412 - 28423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Appel, A. Rupf, M. M. Weck, O. Schoor, T. H. Brummendorf, T. Weinschenk, F. Grunebach, and P. Brossart Effects of Imatinib on Monocyte-Derived Dendritic Cells Are Mediated by Inhibition of Nuclear Factor-{kappa}B and Akt Signaling Pathways Clin. Cancer Res., March 1, 2005; 11(5): 1928 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Dietz, L. Souan, G. J. Knutson, P. A. Bulur, M. R. Litzow, and S. Vuk-Pavlovic Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo Blood, August 15, 2004; 104(4): 1094 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Thompson, B. J. O'Sullivan, H. Beamish, and R. Thomas T Cells Signaled by NF-{kappa}B- Dendritic Cells Are Sensitized Not Anergic to Subsequent Activation J. Immunol., August 1, 2004; 173(3): 1671 - 1680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Speirs, L. Lieberman, J. Caamano, C. A. Hunter, and P. Scott Cutting Edge: NF-{kappa}B2 Is a Negative Regulator of Dendritic Cell Function J. Immunol., January 15, 2004; 172(2): 752 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Appel, A. M. Boehmler, F. Grunebach, M. R. Muller, A. Rupf, M. M. Weck, U. Hartmann, V. L. Reichardt, L. Kanz, T. H. Brummendorf, et al. Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells Blood, January 15, 2004; 103(2): 538 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Lindner, M. A. Kharfan-Dabaja, E. Ayala, D. Kolonias, L. M. Carlson, Y. Beazer-Barclay, U. Scherf, J. H. Hnatyszyn, and K. P. Lee Induced Dendritic Cell Differentiation of Chronic Myeloid Leukemia Blasts Is Associated with Down-Regulation of BCR-ABL J. Immunol., August 15, 2003; 171(4): 1780 - 1791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sharma, M. Stolina, S.-C. Yang, F. Baratelli, J. F. Lin, K. Atianzar, J. Luo, L. Zhu, Y. Lin, M. Huang, et al. Tumor Cyclooxygenase 2-dependent Suppression of Dendritic Cell Function Clin. Cancer Res., March 1, 2003; 9(3): 961 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wirths, J. Reichert, F. Grunebach, and P. Brossart Activated CD8+ T Lymphocytes Induce Differentiation of Monocytes to Dendritic Cells and Restore the Stimulatory Capacity of Interleukin 10-treated Antigen-presenting Cells Cancer Res., September 1, 2002; 62(17): 5065 - 5068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. O'Sullivan and R. Thomas CD40 Ligation Conditions Dendritic Cell Antigen-Presenting Function Through Sustained Activation of NF-{kappa}B J. Immunol., June 1, 2002; 168(11): 5491 - 5498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Steptoe, J. M. Ritchie, and L. C. Harrison Increased Generation of Dendritic Cells from Myeloid Progenitors in Autoimmune-Prone Nonobese Diabetic Mice J. Immunol., May 15, 2002; 168(10): 5032 - 5041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Saemann, O. Parolini, G. A. Bohmig, P. Kelemen, P.-M. Krieger, J. Neumuller, K. Knarr, W. Kammlander, W. H. Horl, C. Diakos, et al. Bacterial metabolite interference with maturation of human monocyte-derived dendritic cells J. Leukoc. Biol., February 1, 2002; 71(2): 238 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B M J Foxwell, S Yoshimura, J Bondeson, F M Brennan, and M Feldmann High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approach Ann Rheum Dis, November 1, 2001; 60(90003): iii13 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ohishi, B. Varnum-Finney, R. E. Serda, C. Anasetti, and I. D. Bernstein The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells Blood, September 1, 2001; 98(5): 1402 - 1407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Conron, J. Bondeson, P. Pantelidis, H. L. C. Beynon, M. Feldmann, R. M. duBois, and B. M. J. Foxwell Alveolar Macrophages and T Cells from Sarcoid, but Not Normal Lung, Are Permissive to Adenovirus Infection and Allow Analysis of NF-kappa B-Dependent Signaling Pathways Am. J. Respir. Cell Mol. Biol., August 1, 2001; 25(2): 141 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yoshimura, J. Bondeson, B. M. J. Foxwell, F. M. Brennan, and M. Feldmann Effective antigen presentation by dendritic cells is NF-{{kappa}}B dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines Int. Immunol., May 1, 2001; 13(5): 675 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Morelli, A. T. Larregina, R. W. Ganster, A. F. Zahorchak, J. M. Plowey, T. Takayama, A. J. Logar, P. D. Robbins, L. D. Falo, and A. W. Thomson Recombinant Adenovirus Induces Maturation of Dendritic Cells via an NF-kappa B-Dependent Pathway J. Virol., October 15, 2000; 74(20): 9617 - 9628. [Abstract] [Full Text]
|
|
|
|
|
|
B. J. O'Sullivan, K. P. A. MacDonald, A. R. Pettit, and R. Thomas RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function PNAS, October 10, 2000; 97(21): 11421 - 11426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Lyakh, G. K. Koski, W. Telford, R. E. Gress, P. A. Cohen, and N. R. Rice Bacterial Lipopolysaccharide, TNF-{alpha}, and Calcium Ionophore Under Serum-Free Conditions Promote Rapid Dendritic Cell-Like Differentiation in CD14+ Monocytes Through Distinct Pathways That Activate NF-{kappa}B J. Immunol., October 1, 2000; 165(7): 3647 - 3655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Brossart, A. Zobywalski, F. Grünebach, L. Behnke, G. Stuhler, V. L. Reichardt, L. Kanz, and W. Brugger Tumor Necrosis Factor {{alpha}} and CD40 Ligand Antagonize the Inhibitory Effects of Interleukin 10 on T-Cell Stimulatory Capacity of Dendritic Cells Cancer Res., August 1, 2000; 60(16): 4485 - 4492. [Abstract] [Full Text]
|
|
|
|
|
|
E. R. Fields, B. J. Seufzer, E. M. Oltz, and S. Miyamoto A Switch in Distinct I{kappa}B{alpha} Degradation Mechanisms Mediates Constitutive NF-{kappa}B Activation in Mature B Cells J. Immunol., May 1, 2000; 164(9): 4762 - 4767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Kiertscher, J. Luo, S. M. Dubinett, and M. D. Roth Tumors Promote Altered Maturation and Early Apoptosis of Monocyte-Derived Dendritic Cells J. Immunol., February 1, 2000; 164(3): 1269 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Neumann, H.-W. Fries, C. Scheicher, P. Keikavoussi, A. Kolb-Maurer, E.-B. Brocker, E. Serfling, and E. Kampgen Differential expression of Rel/NF-kappa B and octamer factors is a hallmark of the generation and maturation of dendritic cells Blood, January 1, 2000; 95(1): 277 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xia, S. Chen, Y. Wang, N. Mackman, G. Ku, D. Lo, and L. Feng RelB Modulation of Ikappa Balpha Stability as a Mechanism of Transcription Suppression of Interleukin-1alpha (IL-1alpha ), IL-1beta , and Tumor Necrosis Factor Alpha in Fibroblasts Mol. Cell. Biol., November 1, 1999; 19(11): 7688 - 7696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Grohmann, R. Bianchi, M. L. Belladonna, C. Vacca, S. Silla, E. Ayroldi, M. C. Fioretti, and P. Puccetti IL-12 Acts Selectively on CD8{alpha}- Dendritic Cells to Enhance Presentation of a Tumor Peptide In Vivo J. Immunol., September 15, 1999; 163(6): 3100 - 3105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Koski, G. N. Schwartz, D. E. Weng, B. J. Czerniecki, C. Carter, R. E. Gress, and P. A. Cohen Calcium Mobilization in Human Myeloid Cells Results in Acquisition of Individual Dendritic Cell-Like Characteristics Through Discrete Signaling Pathways J. Immunol., July 1, 1999; 163(1): 82 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. St. Louis, J. B. Woodcock, G. Fransozo, P. J. Blair, L. M. Carlson, M. Murillo, M. R. Wells, A. J. Williams, D. S. Smoot, S. Kaushal, et al. Evidence for Distinct Intracellular Signaling Pathways in CD34+ Progenitor to Dendritic Cell Differentiation from a Human Cell Line Model J. Immunol., March 15, 1999; 162(6): 3237 - 3248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Verhasselt, W. Vanden Berghe, N. Vanderheyde, F. Willems, G. Haegeman, and M. Goldman N-Acetyl-L-Cysteine Inhibits Primary Human T Cell Responses at the Dendritic Cell Level: Association with NF-{kappa}B Inhibition J. Immunol., March 1, 1999; 162(5): 2569 - 2574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hsing and G. A. Bishop Requirement for Nuclear Factor-{kappa}B Activation by a Distinct Subset of CD40-Mediated Effector Functions in B Lymphocytes J. Immunol., March 1, 1999; 162(5): 2804 - 2811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Madruga, N. Koritschoner, S. Diebold, S. Kurz, and M Zenke Polarised expression pattern of focal contact proteins in highly motile antigen presenting dendritic cells J. Cell Sci., January 6, 1999; 112(11): 1685 - 1696. [Abstract] [PDF]
|
|
|
|
|
|
F. Santiago-Schwarz, M. McCarthy, J. Tucci, and S. E. Carsons Neutralization of Tumor Necrosis Factor Activity Shortly After the Onset of Dendritic Cell Hematopoiesis Reveals a Novel Mechanism for the Selective Expansion of the CD14-Dependent Dendritic Cell Pathway Blood, August 1, 1998; 92(3): 745 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Solan, H. Miyoshi, E. M. Carmona, G. D. Bren, and C. V. Paya RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100 J. Biol. Chem., January 4, 2002; 277(2): 1405 - 1418. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
